Nov. 26 2009
Source Page: Structured patient education in diabetes: report from the patient education working group. Incl. appendices. 69 p.Found: Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with
Written Evidence Mar. 05 2024
Inquiry: Veterinary medicines and the Windsor FrameworkFound: are required for horses to compete in any major competitions will be discontinued. 29.If supply of insulin
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 27 March 2023Found: When Janumet is used in combination with insulin, a lower dose of insulin may be required to reduce
Asked by: Steve McCabe (Labour - Birmingham, Selly Oak)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the adequacy of the availability of continuous glucose monitoring for people with type-1 diabetes; and if she will make an assessment of the potential merits of taking steps to increase access to that monitoring.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Long Term Plan made a commitment that 20% of people with type 1 diabetes would benefit from life changing flash glucose monitors. Data up to the third quarter of 2022/23 shows that 73% of people with type 1 diabetes were prescribed flash glucose monitoring, against the 20% target. As a result of the recent National Institute for Health and Care Excellence guidance that also recommended that insulin dependent patients with type 2 diabetes should benefit from flash or continuous glucose monitoring devices, we are now starting to see a growth in prescription within the type 2 diabetes patient group.
Variation ratio in prescribing between the most and least affluent Indices of Multiple Deprivation (IMD) quintiles has been monitored on a quarterly basis. Variation between these IMD quintiles has reduced in every English region. When the programme started, Flash was twice as likely to be prescribed to patients living in the most affluent areas. The current ratio between most and least affluent geographies is now at a ratio of 1 to 1.02, meaning there is virtually parity between the most and least deprived patient groups across England.
Jan. 10 2024
Source Page: Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027Found: Often this can be because of prolonged excess insulin secretion as a result of insulin resistance.
Feb. 09 2010
Source Page: Table showing health technologies appraised by the National Institute for Health and Clinical Excellence from May 2005 to 2010. 6 p.Found: cognitive behavioural therapy (CCBT) packageDepression and anxietyMTAOnly in research2006.0Inhaled insulin
Jan. 25 2024
Source Page: Four-dose Mounjaro “KwikPen” approved by MHRA for diabetes and weight managementFound: significant decreases in fasting glucose levels compared to either placebo or an active control (semaglutide, insulin
Mentions:
1: Minto, Jenni (SNP - Argyll and Bute) more than 1,700 children—who live with type 1 diabetes to access life-changing technologies, such as insulin - Speech Link
2: Choudhury, Foysol (Lab - Lothian) A constituent in Lothian, Stephen, was granted access to an insulin pump after a shocking three years - Speech Link
Nov. 29 2023
Source Page: Extension and concessions granted to help industry with medical certificationFound: The MCA has also announced a new pilot project to consider certain insulin-treated solo fishers the opportunity
Jul. 03 2008
Source Page: Safety in doses: medication safety incidents in the NHS. Fourth report from the Patient Safety Observatory. 72 p.Found: insulin illustrate the importance of the timing of insulin doses in relation to food intake and other